Global Research Antibodies Market 2022-2028

May 2022 | 71 pages | ID: G9CDEE55DD1DEN
Gen Consulting Company

Abstracts

Antibodies are proteins produced by the immune system in response to the introduction of a foreign body (known as an antigen). Antibodies have a variety of uses - in basic research, diagnostic tests and theraputics. As a cornerstone of the body's immune response, antibodies can provide significant data to support scientists' research. The global research antibodies market is anticipated to reach valuation of ~USD 4,892 million by 2028, representing a CAGR of 5.6% from 2022 to 2028 as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global research antibodies market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the research antibodies industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, clonality, major reactivities, technology, end user, and region. The global market for research antibodies can be segmented by product: primary antibodies, secondary antibodies. The primary antibodies segment held the largest revenue share in 2021. Research antibodies market is further segmented by clonality: monoclonal antibodies, polyclonal antibodies. Among these, the polyclonal antibodies segment was accounted for the highest revenue generator in 2021. Based on major reactivities, the research antibodies market is segmented into: human, mouse, rat. The human segment captured the largest share of the market in 2021. On the basis of technology, the research antibodies market also can be divided into: enzyme-linked immunosorbent assay (ELISA), flow cytometry, immunofluorescent staining, immunohistochemistry, western blotting. Research antibodies market by end user is categorized into: pharma & biotech companies, academic and research institutions. The research antibodies market by region can be segmented into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:

• primary antibodies
• secondary antibodies

By clonality:

• monoclonal antibodies
• polyclonal antibodies

By major reactivities:

• human
• mouse
• rat

By technology:

• enzyme-linked immunosorbent assay (ELISA)
• flow cytometry
• immunofluorescent staining
• immunohistochemistry
• western blotting

By end user:

• pharma & biotech companies
• academic and research institutions

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report has also analysed the competitive landscape of the global research antibodies market with some of the key players being Abcam plc, Agilent Technologies, Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad AbD Serotec GmbH, Bio-Techne Corporation, Cell Signaling Technology, Inc., F. Hoffmann-La Roche AG, Merck KGaA, Santa Cruz Biotechnology, Inc., Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global research antibodies market.
• To classify and forecast the global research antibodies market based on product, clonality, major reactivities, technology, end user, region.
• To identify drivers and challenges for the global research antibodies market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global research antibodies market.
• To identify and analyze the profile of leading players operating in the global research antibodies market.

Why Choose This Report

• Gain a reliable outlook of the global research antibodies market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Primary antibodies
Secondary antibodies

PART 6. MARKET BREAKDOWN BY CLONALITY

Monoclonal antibodies
Polyclonal antibodies

PART 7. MARKET BREAKDOWN BY MAJOR REACTIVITIES

Human
Mouse
Rat

PART 8. MARKET BREAKDOWN BY TECHNOLOGY

Enzyme-linked immunosorbent assay (ELISA)
Flow cytometry
Immunofluorescent staining
Immunohistochemistry
Western blotting

PART 9. MARKET BREAKDOWN BY END USER

Pharma & biotech companies
Academic and research institutions

PART 10. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 11. KEY COMPANIES

Abcam plc
Agilent Technologies, Inc.
Beckman Coulter Inc.
Becton, Dickinson and Company
Bio-Rad AbD Serotec GmbH
Bio-Techne Corporation
Cell Signaling Technology, Inc.
F. Hoffmann-La Roche AG
Merck KGaA
Santa Cruz Biotechnology, Inc.
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER